Synta Pharmaceuticals (SNTA) Announces Appointment Of Steven Bernitz As Senior Vice President, Corporate Development
12/20/2013 6:54:35 AM
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced the appointment of Steven Bernitz as Senior Vice President, Corporate Development. Mr. Bernitz brings over 20 years' experience in corporate strategy, business leadership and transactional experience in life sciences.
Help employers find you! Check out all the jobs and post your resume.
comments powered by